AVA-032

N/A

Report date: 2023/12/07 11:44:26

Base Information

Drug NameAVA-032
Drug Alias NameAVA-032
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-15 modulatorsAnti-Programmed death-ligand 1
TargetsInterleukin-15Programmed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvacta Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvacta Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A